33.89
Precedente Chiudi:
$34.12
Aprire:
$34.65
Volume 24 ore:
4.81M
Relative Volume:
0.50
Capitalizzazione di mercato:
$29.74B
Reddito:
$29.14B
Utile/perdita netta:
$1.07B
Rapporto P/E:
28.34
EPS:
1.1956
Flusso di cassa netto:
$1.05B
1 W Prestazione:
-4.30%
1M Prestazione:
-14.61%
6M Prestazione:
-28.62%
1 anno Prestazione:
+0.00%
Medline Inc Stock (MDLN) Company Profile
Nome
Medline Inc
Settore
Industria
Telefono
847-949-3000
Indirizzo
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MDLN
Medline Inc
|
33.90 | 29.94B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ISRG
Intuitive Surgical Inc
|
400.16 | 138.20B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
186.94 | 49.24B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
74.27 | 35.55B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
230.22 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-11 | Ripresa | Citigroup | Buy |
| 2026-02-05 | Iniziato | Tigress Financial | Buy |
| 2026-01-21 | Reiterato | BTIG Research | Buy |
| 2026-01-12 | Iniziato | Citigroup | Buy |
| 2026-01-12 | Iniziato | Deutsche Bank | Hold |
| 2026-01-12 | Iniziato | Evercore ISI | Outperform |
| 2026-01-12 | Iniziato | Goldman | Buy |
| 2026-01-12 | Iniziato | JP Morgan | Overweight |
| 2026-01-12 | Iniziato | Jefferies | Buy |
| 2026-01-12 | Iniziato | Leerink Partners | Outperform |
| 2026-01-12 | Iniziato | Mizuho | Outperform |
| 2026-01-12 | Iniziato | Morgan Stanley | Overweight |
| 2026-01-12 | Iniziato | Piper Sandler | Overweight |
| 2026-01-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-12 | Iniziato | Robert W. Baird | Outperform |
| 2026-01-12 | Iniziato | Rothschild & Co Redburn | Neutral |
| 2026-01-12 | Iniziato | Stifel | Buy |
| 2026-01-12 | Iniziato | TD Cowen | Buy |
| 2026-01-12 | Iniziato | Truist | Buy |
| 2026-01-12 | Iniziato | UBS | Buy |
| 2026-01-12 | Iniziato | Wells Fargo | Equal Weight |
| 2026-01-12 | Iniziato | William Blair | Outperform |
| 2026-01-12 | Iniziato | Wolfe Research | Outperform |
Mostra tutto
Medline Inc Borsa (MDLN) Ultime notizie
MDLN News Today | Why did Medline stock go down today? - MarketBeat
Medline stock drops over 7% after FDA cites maj... - Pluang
Medline tallies tariff refunds as Q2 sales rise 11.6% - Digital Commerce 360
Medline (NASDAQ:MDLN) Major Shareholder Sells $3,580,000.00 in Stock - MarketBeat
Medline (NASDAQ:MDLN) Major Shareholder Private Ltd Gic Sells 1,500,000 Shares of Stock - MarketBeat
GIC-tied Medline Inc. (MDLN) sells 1.6M shares at $35.80 in August 2026 - Stock Titan
Medline Inc. (MDLN) Stock Plummets 7% Amid FDA Warning Letter and Securities Law Probe - Kalkine Media
MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - barchart.com
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of a - The National Law Review
Medline Inc. (MDLN) Shares Drop 7% After FDA Warning Letter Triggers Securities Law Investigation - kalkine.ca
Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating - marketscreener.com
Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to - The National Law Review
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - Morgan County Citizen
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law ViolationsInvestors are Encouraged to Contact the Firm - The Globe and Mail
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - Benzinga
Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis - Kalkine
Medline faces securities probe after FDA cites manufacturing violations, stock drops 7%. - pluang.com
Kaplan Fox Investigates Medline Inc. Over Alleged Securities Violations Following FDA Warning Letters - kalkine.ca
GIC Private Ltd sells $21m Medline Inc. (MDLN) shares By Investing.com - Investing.com South Africa
Hellman & Friedman funds (MDLN) report 153M Medline Class A shares in latest ownership update - Stock Titan
Tigress Financial lowers Medline stock price target on fire impact By Investing.com - Investing.com UK
Private Ltd Gic Sells 590,284 Shares of Medline (NASDAQ:MDLN) Stock - MarketBeat
Tigress Financial lowers Medline stock price target on fire impact - Investing.com
GIC Private Ltd sells $21m Medline Inc. (MDLN) shares - Investing.com
Wells Fargo & Company Cuts Medline (NASDAQ:MDLN) Price Target to $34.00 - MarketBeat
MEDLINE INC. : TD COWEN CUTS TARGET PRICE TO $45 FROM $53 - Bitget
Medline $MDLN Shares Acquired by Cetera Investment Advisers - MarketBeat
Bank of America Corp DE Lowers Holdings in Medline $MDLN - marketbeat.com
Blackstone entities (NASDAQ: MDLN) report 153.3M Medline shares, 16.5% stake - Stock Titan
Medline stock drops over 19% after FDA cites ma... - Pluang
NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - PR Newswire
Medline Inc. (MDLN) major holder sells 2,248,612 shares, keeps large stake - Stock Titan
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of an Investigation Into Potential Securities Law Violations - barchart.com
Medline Q2 2026 EPS Tops Expectations by 56.2%, Revenue Up 12% - AlphaStreet
FMR LLC discloses 5.5% Medline Inc (MDLN) Class A ownership stake - Stock Titan
Medline Inc. Stock 12‑Month Price Target Cut to $46.69, Implies 27% Upside - TradingView
Medline Inc Azioni (MDLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):